Biotech

Q&A with OneWorld Health CEO Richard Chin

A South San Francisco nonprofit drug development organization, OneWorld Health, is shattering the conventional profit-generating model of pharmaceutical companies by using a social enterprise approach to global health problems. Richard Chin, an internist and CEO of OneWorld Health, said the organization develops new therapies for diseases where there is either no treatment or the cost of treatment is too high.